ISIN: NL0012044747 · Redcare Pharmacy N.V. · © Federal Gazette

Short Selling Alert: AHL Partners LLP

Message date: 18th November 2024

Termsheet of the Shortselling Transaction

As a result of the registered transaction Increased the share of the short position changed from 0,49% to 0,50%. Within the transaction history, this is the 13th adjustment of the short position since the initial commitment of 17th May 2024.
Snapshot transaction history
0,61%
0,56%
0,49%

0,50%

Forty-two (42) companies specializing in short selling have Redcare Pharmacy N.V. on their short-selling radar. The total share of all short selling positions is 30,69%. The largest share is held by Citadel Europe LLP with 6,25%.
Weighting of the position within the overall ranking: 951

XETR:RDC Price indication powered by TradingView

Research & Analysis

Tip: Visual Sitemap

Tip: Hedge Fund Activity Tracker ("HFAT") & SSR Weight-WatchR ("WWR") & New: First Time Target ("FTT") & New Admissions ("NewAD")

360°
SSR reporting for: 18th November 2024

Short Selling Radar (Europe)

Select Country

In this overview, we provide you with visually prepared and enriched with further relevant information short sale holdings for supplementary information and research purposes. The reporting requirements are defined via the specifications of corresponding guidelines and recorded by publicly accessible registers of European supervisory authorities. For validation of the data, consult at least a second source.

Tip: If you have a user account with ayondo, you can use the ayondo smart alerts to be notified when net short positionschange, ratings or ad-hoc announcements of listed companies via auto alert.

Reset filters
This might be interesting for you as well
Equity Story (113)
Analyst Ratings (0)
Directors Dealings (10)
Short Selling (DE) (48)
Short Selling (UK) (0)
Click on that Icon to get Support from AI
ID Logo ISIN Short Seller Share Short Price Position Registered for Chart ChatGPT B/S
1 NL0012044747 AHL Partners LLP 0,50% Increased 18th November 2024 B/S
2 NL0012044747 Qube Research & Technologies Limited 0,87% decreased 18th November 2024 B/S
3 NL0012044747 Citadel Advisors LLC 0,50% Increased 17th October 2024 B/S
4 NL0012044747 JPMorgan Asset Management (UK) Ltd 0,82% Increased 5th September 2024 B/S
5 NL0012044747 Arrowstreet Capital, Limited Partnership 0,78% Opened 21st December 2023 B/S
6 NL0012044747 Qube Research & Technologies Limited 0,68% decreased 29th June 2023 B/S
7 NL0012044747 Qube Research & Technologies Limited 0,96% decreased 9th June 2023 B/S
8 NL0012044747 Qube Research & Technologies Limited 0,89% decreased 1st June 2023 B/S
9 NL0012044747 Arrowstreet Capital, Limited Partnership 0,82% Opened 19th May 2023 B/S
10 NL0012044747 Qube Research & Technologies Limited 1,10% Opened 9th May 2023 B/S
11 NL0012044747 Marshall Wace LLP 1,11% Opened 12th September 2022 B/S
12 NL0012044747 PDT Partners, LLC 0,60% Opened 10th May 2022 B/S
13 NL0012044747 Arrowstreet Capital, Limited Partnership 0,92% Increased 24th August 2021 B/S
14 NL0012044747 Arrowstreet Capital, Limited Partnership 0,71% Increased 12th August 2021 B/S
15 NL0012044747 BlackRock Institutional Trust Company, National Association 0,55% decreased 27th July 2021 B/S
16 NL0012044747 Greenvale Capital LLP 0,94% decreased 25th June 2021 B/S
17 NL0012044747 LMR Partners LLP 0,58% Opened 16th September 2020 B/S
18 NL0012044747 Citadel Advisors LLC 0,50% Opened 11th August 2020 B/S
19 NL0012044747 Citadel Europe LLP 6,25% Increased 20th July 2020 B/S
20 NL0012044747 OCH-ZIFF MANAGEMENT EUROPE LIMITED 0,58% Opened 18th April 2018 B/S
More Redcare Pharmacy N.V. related information
Type Total Last Made by Go to
Equity Story 113 5th November 2024 EQS Group AG EQS
Corporate Research 0 - - Corporate Research
Directors Dealings 10 9th August 2024 Holler, Theresa Margarete DD
Short Seller (DE) 48 18th November 2024 Qube Research & Technologies Limited SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Note

The content compiled in this section and all sub-pages is for general information purposes. It is not an investment or other form of advice. The information has been prepared with the utmost care and accuracy. Source data has been obtained from the respective institution or agency responsible for the publication. If you are interested in publications on net short positions related to a specific country, you can go to the individual overviews from here. Before further inclusion, e.g. in investment or investment decisions, validation via another source is recommended.

An update is usually EoD. ayondo assumes no responsibility for the quality and timeliness of the content presented or permanent technical availability.

Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

The EU Short Selling Regulation specifies which transparency obligations must be fulfilled with regard to short selling activities. According to the specifications, there is a two-tier transparency system for net short positions in shares, which is linked to reporting obligations if thresholds are reached or fallen below. 

Net short positions must be notified to the competent national authority (Articles 5 and 6 EU Short Selling Regulation). According to Article 5 (1) and (2) EU Short Selling Regulation, an initial notification has to be made when the net short position reaches 0.1% of the issued share capital of the company concerned (1st step). If the net short position reaches 0.5% of the issued share capital, it must also be published in the respective reporting registers in accordance with Art. 6 (1) and (2) EU Short Selling Regulation (2nd stage). 

Please note: The information available here has been taken from publicly available sources and edited visually and textually for improved usability. Before using this data, we recommend that you perform a plausibility check of the source data. These can be found at institutions and authorities that are authorized to collect and publish them.  In the section "Net short positions" you can access the individual publications via a tabular overview. A search function as well as further filters allow you to specifically find further detailed information.

We have compiled further information, explanations and notes for you in this area.

We offer you two different views for use here. The default view displays the processed information in chronological order as a "Card" view. You can change this view by selecting the "Table" view. We explicitly point out that the compilation serves exclusively to make the processes derived from the EU Short Sale Regulation more usable for information seekers. This includes topics such as user-friendliness, user experience and networked data. The updating of the data stock is usually carried out in an end-of-day process, which also takes quality assurance aspects into account. Therefore, we cannot assume liability for the accuracy, completeness and timeliness of the data, despite careful checking. In particular, we assume no liability for any damages or consequences arising from the direct or indirect use of the content provided. 

Financial literacy represents one of the key qualifications in an increasingly fast and complex world. Through our developments, we contribute to a process that the German financial regulator recently described as "strengthening financial knowledge at the point of sale". Our information offering is designed to promote financial literacy.